These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12083906)

  • 1. A versatile prodrug approach for liposomal core-loading of water-insoluble camptothecin anticancer drugs.
    Liu X; Lynn BC; Zhang J; Song L; Bom D; Du W; Curran DP; Burke TG
    J Am Chem Soc; 2002 Jul; 124(26):7650-1. PubMed ID: 12083906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and mechanisms of activation of alpha-amino acid ester prodrugs of camptothecins.
    Song L; Bevins R; Anderson BD
    J Med Chem; 2006 Jul; 49(14):4344-55. PubMed ID: 16821794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
    Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
    J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.
    Joguparthi V; Anderson BD
    J Pharm Sci; 2008 Jan; 97(1):433-54. PubMed ID: 17918731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38.
    Bala V; Rao S; Boyd BJ; Prestidge CA
    J Control Release; 2013 Nov; 172(1):48-61. PubMed ID: 23928356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors.
    Fang T; Dong Y; Zhang X; Xie K; Lin L; Wang H
    Int J Pharm; 2016 Oct; 512(1):39-48. PubMed ID: 27544846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of small interfering RNA using a camptothecin prodrug as the carrier.
    Tang Q; Cao B; Cheng G
    Chem Commun (Camb); 2014 Feb; 50(11):1323-5. PubMed ID: 24343195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects.
    Du Y; Zhang W; He R; Ismail M; Ling L; Yao C; Fu Z; Li X
    Bioorg Med Chem; 2017 Jun; 25(12):3247-3258. PubMed ID: 28465086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymersome nanoreactors with tumor pH-triggered selective membrane permeability for prodrug delivery, activation, and combined oxidation-chemotherapy.
    Mukerabigwi JF; Yin W; Zha Z; Ke W; Wang Y; Chen W; Japir AAMM; Wang Y; Ge Z
    J Control Release; 2019 Jun; 303():209-222. PubMed ID: 31026547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome transport of hydrophobic drugs: gel phase lipid bilayer permeability and partitioning of the lactone form of a hydrophobic camptothecin, DB-67.
    Joguparthi V; Xiang TX; Anderson BD
    J Pharm Sci; 2008 Jan; 97(1):400-20. PubMed ID: 17879989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimeric camptothecin derived phospholipid assembled liposomes with high drug loading for cancer therapy.
    Fang S; Hou Y; Ling L; Wang D; Ismail M; Du Y; Zhang Y; Yao C; Li X
    Colloids Surf B Biointerfaces; 2018 Jun; 166():235-244. PubMed ID: 29604567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy.
    Xing J; Zhang X; Wang Z; Zhang H; Chen P; Zhou G; Sun C; Gu N; Ji M
    Int J Nanomedicine; 2019; 14():5201-5213. PubMed ID: 31371956
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of intraliposomal pH and its effect on membrane partitioning and passive loading of a hydrophobic camptothecin, DB-67.
    Joguparthi V; Feng S; Anderson BD
    Int J Pharm; 2008 Mar; 352(1-2):17-28. PubMed ID: 18065174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting.
    Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z
    Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antitumor activity of a self-assembling camptothecin and capecitabine hybrid prodrug for improved efficacy.
    Ma W; Su H; Cheetham AG; Zhang W; Wang Y; Kan Q; Cui H
    J Control Release; 2017 Oct; 263():102-111. PubMed ID: 28082170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Bottom-up" Construction of Multi-Polyprodrug-Arm Hyperbranched Amphiphiles for Cancer Therapy.
    Sun P; Chen D; Deng H; Wang N; Huang P; Jin X; Zhu X
    Bioconjug Chem; 2017 May; 28(5):1470-1480. PubMed ID: 28441015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The self-assembly of anticancer camptothecin-dipeptide nanotubes: a minimalistic and high drug loading approach to increased efficacy.
    Kim SH; Kaplan JA; Sun Y; Shieh A; Sun HL; Croce CM; Grinstaff MW; Parquette JR
    Chemistry; 2015 Jan; 21(1):101-5. PubMed ID: 25384556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity.
    Liu Y; Piao H; Gao Y; Xu C; Tian Y; Wang L; Liu J; Tang B; Zou M; Cheng G
    Int J Nanomedicine; 2015; 10():2295-311. PubMed ID: 25848251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of glutathione responsive glycosylated camptothecin nanosupramolecular prodrug.
    Li W; Chen Z; Liu X; Lian M; Peng H; Zhang C
    Drug Deliv; 2021 Dec; 28(1):1903-1914. PubMed ID: 34519602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions.
    Lundberg BB
    Anticancer Drug Des; 1998 Jul; 13(5):453-61. PubMed ID: 9702210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.